FEXALLEGRA

FEXALLEGRA NASAL 1 MG/ML + 3.55 MG/ML NASAL SPRAY, SOLUTION 1 BOTTLE OF 10 ML

FEXALLEGRA NASAL 1 MG/ML + 3.55 MG/ML NASAL SPRAY, SOLUTION 1 BOTTLE OF 10 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Name
Fexallegra nasal 1 mg/ml + 3.55 mg/ml nasal spray, solution
Tramazoline + chlorpheniramine


What is it and what is it for?
Fexallegra Nasal is a nasal spray containing tramazoline and chlorpheniramine. Fexallegra Nasal is used in adults and adolescents aged 12 years and older to treat the symptoms of allergic rhinitis (e.g., hay fever).
Allergic rhinitis causes a runny nose, sneezing, and swelling of the nasal mucosa, causing a feeling of stuffiness. Fexallegra nasal reduces nasal swelling and irritation and relieves sneezing, itching, and stuffy and runny nose.

Contact your doctor if you do not feel better or if you feel worse after 4 days.


What you need to know before taking the medicine
Do not use Fexallegra nasal
- if you are allergic to tramazoline, chlorpheniramine, benzalkonium chloride or any of the other ingredients of this medicine (listed in section 6);
- if you suffer from inflammation of the nasal passages with little or no nasal discharge (dry rhinitis);
- if you suffer from heart disease and very high blood pressure (severe arterial hypertension);
- if you suffer from a disease characterized by an increase in the pressure of the fluid inside the eye (acute angle glaucoma);
- if you suffer from a disease in which the thyroid produces too much hormone (hyperthyroidism);
- if you suffer from a disease characterised by an increase in the volume of the prostate (prostatic hypertrophy);
- if you have had head surgery performed through the nose;
- if under 12 years of age;
- if you are pregnant or breastfeeding (see section “Fertility, pregnancy and breastfeeding”).


Warnings and precautions
Use Fexallegra nasal only after consulting your doctor:
- if you are elderly (you may have an increased risk of experiencing side effects, in particular, dizziness, sedation, confusion, low blood pressure and dry mouth; especially male patients may also have an increased risk of experiencing urinary retention);
- if you suffer from diabetes mellitus;
- if you suffer from pheochromocytoma (a tumor of the adrenal glands);
- if you suffer from porphyria (a disease that interferes with the production of hemoglobin, the substance that allows red blood cells to carry oxygen in the blood);
- if you suffer from mild to moderate increases in blood pressure (mild-moderate arterial hypertension). Consult your doctor even if you have had these problems in the past.

Prolonged use of topical products can cause irritation and inflammation of the nasal mucosa and paranasal sinuses. Prolonged use can also lead to habituation to the medication. Swelling of the nasal mucosa (nasal edema) may occur when the drug's effect wears off.

Do not use Fexallegra nasal by mouth because it can be toxic.
Avoid contact of the liquid with your eyes to avoid irritation.

Children
Do not give this medicine to children under 12 years of age.

Caution for athletes: this product contains substances prohibited for doping. Do not use in any manner other than those listed, in terms of dosage and route of administration.


Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

If irritation, inflammation, or thinning of the nasal mucosa occurs during treatment, discontinue treatment and consult your doctor to initiate appropriate therapy.

The following side effects may occur following the use of Fexallegra nasal: the frequency of these side effects is not known.

Immune system disorders:
- allergy (swelling of the skin and mucous membranes).

Psychiatric disorders:
- perception of things that do not exist in reality (hallucinations);
- insomnia;
- restlessness.

Nervous system disorders:
- drowsiness;
- sedation;
- heachache;
- dizziness;
- alteration of taste (dysgeusia).

Heart disease:
- alterations in heart rhythm (arrhythmias);
- increased heart rate (tachycardia);
- heightened perception of heartbeats (palpitations).

Respiratory and chest disorders:
- nosebleeds (epistaxis);
- swelling of the nasal mucosa (nasal edema);
- burning nose;
- dryness of the nasal mucosa;
- runny nose (rhinorrhea);
- sneezing.

Gastrointestinal disorders:
- nausea.

Skin and subcutaneous tissue disorders:
- skin rash;
- itching.

Systemic disorders and conditions related to the administration site:
- fatigue.

Alteration of diagnostic tests:
- increased blood pressure.

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.

FEXALLEGRA

FEXALLEGRA NASAL 1 MG/ML + 3.55 MG/ML NASAL SPRAY, SOLUTION 1 BOTTLE OF 10 ML

FEXALLEGRA NASAL 1 MG/ML + 3.55 MG/ML NASAL SPRAY, SOLUTION 1 BOTTLE OF 10 ML

MINSAN code: 027910013
Previous price: €14,90
Regular price €14,90
Regular price €0,00 Sale price €14,90
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.